Mercy’s cancer surgeons and their clinical team are recognized nationally as leaders in aggressive cytoreductive surgery and HIPEC. Due to the complexity of the combined therapies, surgeons must be appropriately trained and experienced to offer these treatment methods.

The Surgical Oncology team at Mercy in Baltimore performs these procedures on a frequent basis and offers a high level of expertise to patients facing a diagnosis of peritoneal cancer.

Dr. Armando Sardi of Surgical Oncology at Mercy Medical Center in Baltimore, Maryland, is widely regarded for his training and skills in utilizing Hyperthermic intraperitoneal chemotherapy (HIPEC) to treat advanced stages of abdominal cancer (peritoneal surface malignancies). Dr. Sardi and an experienced team of oncologists work with a specialized clinical team at Mercy to perform this procedure with a high level of expertise for patients facing a diagnosis of peritoneal cancer.